We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases. Design Therapeutics Inc is a preclinical-stage biopharmaceutical company. It is a pioneering novel small-molecule therapeutic candidate, called gene-targeted chimera, that are designed to be disease-modifying and target the underlying cause of inherited nucleotide repeat expansion diseases.
Ask ADVFN Intelligence (AI)
CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic...
Fuchs Endothelial Corneal Dystrophy (FECD) Phase 1 Trial Initiated with Data Expected in the First Half of 2025 Friedreich Ataxia (FA) Program on Track to Initiate Phase 1 Single Ascending Dose...
CARLSBAD, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious degenerative genetic diseases, today...
Friedreich Ataxia (FA) and Fuchs Endothelial Corneal Dystrophy (FECD) Programs on Track and Advancing Toward Clinical Trials Active Research Pipeline with Programs Progressing in Myotonic...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.145 | 2.3751023751 | 6.105 | 6.45 | 5.16 | 270186 | 6.01331725 | CS |
| 4 | 0.69 | 12.4100719424 | 5.56 | 7.05 | 5.16 | 186355 | 6.21949572 | CS |
| 12 | 0.76 | 13.8433515483 | 5.49 | 7.77 | 4.485 | 168361 | 5.85073822 | CS |
| 26 | 2.68 | 75.0700280112 | 3.57 | 7.77 | 3.15 | 216340 | 5.22315561 | CS |
| 52 | 3.61 | 136.742424242 | 2.64 | 7.77 | 2.245 | 236601 | 4.23723167 | CS |
| 156 | -9.74 | -60.9130706692 | 15.99 | 26.3 | 1.94 | 346322 | 7.00130852 | CS |
| 260 | -21.75 | -77.6785714286 | 28 | 50 | 1.94 | 307909 | 8.44548504 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
